Not checked for notices yet.

INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies

Cornelis M. van Tilburg, Ruth Witt, Melanie Heiss and 18 more

BMC Cancer · 2020

doi:10.1186/s12885-020-07008-8

Cited by papers we hold 2

Epigenetics-targeted drugs: current paradigms and future challenges · 2024
No notice
Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives · 2021
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.